Lupin 2024

Breckenridge Pharmaceutical

Breckenridge set to release Prilosec generic

Breckenridge set to release Prilosec generic

BOCA RATON, Fla. — Breckenridge Pharmaceutical Inc. has earned Food and Drug Administration approval for omeprazole delayed-release capsules, an antacid, in 10-mg, 20-mg, 40-mg dosages. Breckenridge said its omeprazole product, AB-rated to AstraZeneca’s Prilosec, will be manufactured and supplied by its parent company, Laboratorios Dr. Esteve S.A., based in Barcelona, Spain. Launch plans are under

Breckenridge Pharmaceutical to release Nuvigil generic

Breckenridge Pharmaceutical to release Nuvigil generic

BOCA RATON, Fla. — Breckenridge Pharmaceutical Inc. is launching armodafinil tablets (CIV), a medication for promoting wakefulness. Breckenridge said this week that its armodafinil product, which comes in strengths of 50 mg, 150 mg and 250 mg, is a generic version of Nuvigil from by Cephalon Inc., a subsidiary of Teva Pharmaceutical Industries Ltd. Plans

PP_1170x120_10-25-21